1997
DOI: 10.1016/s0002-9149(97)00497-9
|View full text |Cite
|
Sign up to set email alerts
|

Prospective Validation of a Composite End Point in Thrombolytic Trials of Acute Myocardial Infarction (TIMI 4 and 5)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
10
0

Year Published

1999
1999
2016
2016

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 20 publications
(10 citation statements)
references
References 24 publications
0
10
0
Order By: Relevance
“…Event-free survival—which reflects both mortality and hospitalizations—was chosen as the primary end point to capture a more complete picture of disease progress rather than mortality alone 3032. Monthly follow-up phone calls and hospital administrative databases were reviewed to identify events.…”
Section: Methodsmentioning
confidence: 99%
“…Event-free survival—which reflects both mortality and hospitalizations—was chosen as the primary end point to capture a more complete picture of disease progress rather than mortality alone 3032. Monthly follow-up phone calls and hospital administrative databases were reviewed to identify events.…”
Section: Methodsmentioning
confidence: 99%
“…The benefits, risks, and influence on sample size computation of using CEs have been broadly studied (1,2,6,7,9,13,14). However, to our knowledge, the impact of the strength of the relationship between CE components on such computation has not been addressed in depth (3,4,(15)(16)(17)(18).…”
Section: Pop-up Notesmentioning
confidence: 99%
“…MACE was defined as the composite incidence of death, recurrent infarction, repeat PCI or a LVEF ≤ 30%. The combination of death and non-fatal major events as recurrent infarction, repeat intervention, and heart failure has been shown to be a valid predictor of 1-year mortality [17,18]. If in one patient more than one event occurred, these events accounted for one MACE.…”
Section: Methodsmentioning
confidence: 99%